| 摘要 |
<p>The present invention relates to compositions and methods for cancer diagnosis and therapy, including but not limited to, cancer markers. In particular, the present invention relates to HERV-K(HML-2) target titers as diagnostic markers, and HERV-K(HML-2) therapeutic targets for HIV-related cancers, and other cancers.</p> |
| 申请人 |
THE REGENTS OF THE UNIVERSITY OF MICHIGAN;CONTRERAS-GALINDO, RAFAEL;KAPLAN, MARK, H.;MARKOVITZ, DAVID;DOSIK, MICHAEL, H. |
发明人 |
CONTRERAS-GALINDO, RAFAEL;KAPLAN, MARK, H.;MARKOVITZ, DAVID;DOSIK, MICHAEL, H. |
